Lower-Volume Centers Less Likely to Follow Mesothelioma Treatment Guidelines
Mesothelioma patients need to beware of low-volume centers that are less likely to follow mesothelioma treatment guidelines. That is the…
-
-
Longer Mesothelioma Survival Possible with Long-Term Local Chemotherapy
There is evidence that repeatedly rinsing the abdomen with medicine might lead to longer mesothelioma survival after surgery. A rinse… -
Asia | Chemotherapy | International | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments | Updates
Chemotherapy During Mesothelioma Surgery: Is it Dangerous?
A new study finds that chemotherapy during mesothelioma surgery does not raise the risk for complications. That could be good… -
Adjuvant Radiotherapy for Mesothelioma Extends Survival
The largest study ever conducted on adjuvant radiotherapy for mesothelioma shows that it can help patients live longer. Pleural mesothelioma… -
Researchers Name Six Top Mesothelioma Survival Factors
Researchers at the University of Pittsburgh have named what they say are the top six mesothelioma survival factors. According to… -
Chemotherapy | Europe | Immune Systems | International | Multi-Modality Therapy | Research | Treatments | Virus
Chemotherapy for Mesothelioma May Work Better with TroVax
UK researchers say a cancer vaccine called Trovax has the potential to boost the power of chemotherapy for mesothelioma. Chemotherapy… -
Faster Mesothelioma Chemotherapy Deemed “Safe and Feasible”
Researchers in The Netherlands say it may be possible to deliver faster mesothelioma chemotherapy without doing any additional damage to… -
Mesothelioma Staging May be Easier with New Approach
Japanese researchers have introduced a new approach to mesothelioma staging. The new system may make it easier to plan treatment… -
Mesothelioma Surgery PD Comparison
Lung-sparing surgery is another name for pleurectomy/decortication (PD). In PD, surgeons take out as much mesothelioma cancer as they can… -
Ofev Fails to Boost Mesothelioma Survival in New Study
In the quest to develop new, more effective first-line treatments for malignant pleural mesothelioma, it now looks like Ofev (nintedanib)…
